Lung Cancer Clinical Trial
Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy
Summary
This pilot early phase I trial studies the Automated Device for Asthma Monitoring and Management in monitoring adult patients with lung cancer who are undergoing radiation therapy. The Automated Device for Asthma Monitoring and Management may provide useful information to doctors to help monitor adult patients with lung cancer and diagnose certain conditions earlier than traditional means.
Full Description
PRIMARY OBJECTIVES:
I. Determine compliance with the Automated Device for Asthma Monitoring and Management (ADAMM) device in patients receiving radiation therapy (RT) for lung cancer.
SECONDARY OBJECTIVES:
I. Evaluate feasibility of recruitment, acceptability of the ADAMM device, and compliance with electronic patient-reported outcomes (ePROs) in this patient population
Eligibility Criteria
Inclusion Criteria:
Patients are capable of giving informed consent
Patients are eligible to be treated with RT and plan to start treatment
Patients have either metastatic or non-metastatic lung cancer as defined in history and physical
Patients must be able to read or speak English
Women of reproductive potential should have a negative serum or urine pregnancy test within one week prior to radiation planning CT scan
Exclusion Criteria:
Patients who cannot read or speak English
Patients who are not candidates for RT treatment
Women of childbearing potential who are pregnant or breastfeeding
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19107, United States
How clear is this clinincal trial information?